SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
胥阶英
Lv1
40 积分
2022-05-09 加入
最近求助
最近应助
互助留言
c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy
18天前
已完结
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial
20天前
已完结
Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence
21天前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
27天前
已完结
Turning fat into muscle: can this be an alternative to anti-obesity drugs such as semaglutide?
30天前
已完结
Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters
1个月前
已完结
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
2个月前
已完结
IL12/18/21 Preactivation Enhances the Antitumor Efficacy of Expanded γδT Cells and Overcomes Resistance to Anti-PD-L1 Treatment
2个月前
已完结
Interleukin-4 induced 1-mediated resistance to an immune checkpoint inhibitor through suppression of CD8 T cell infiltration in melanoma
2个月前
已完结
The immune suppressor IGSF1 as a potential target for cancer immunotherapy
2个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论